AZELAIC Drug Patent Profile
✉ Email this page to a colleague
When do Azelaic patents expire, and what generic alternatives are available?
Azelaic is a drug marketed by Aurobindo Pharma Usa, Actavis Labs Ut Inc, Encube, Glenmark Speclt, and Sun Pharma Canada. and is included in five NDAs.
The generic ingredient in AZELAIC is azelaic acid. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the azelaic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Azelaic
A generic version of AZELAIC was approved as azelaic acid by ACTAVIS LABS UT INC on November 19th, 2018.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AZELAIC?
- What are the global sales for AZELAIC?
- What is Average Wholesale Price for AZELAIC?
Summary for AZELAIC
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for AZELAIC |
| DailyMed Link: | AZELAIC at DailyMed |
US Patents and Regulatory Information for AZELAIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | AZELAIC ACID | azelaic acid | AEROSOL, FOAM;TOPICAL | 210928-001 | Oct 7, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glenmark Speclt | AZELAIC ACID | azelaic acid | GEL;TOPICAL | 204637-001 | Nov 19, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Actavis Labs Ut Inc | AZELAIC ACID | azelaic acid | GEL;TOPICAL | 208011-001 | Nov 19, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Encube | AZELAIC ACID | azelaic acid | GEL;TOPICAL | 208724-001 | Nov 19, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
